333 related articles for article (PubMed ID: 31021848)
1. Increased Reactivity of the Mesolimbic Reward System after Ketamine Injection in Patients with Treatment-resistant Major Depressive Disorder.
Sterpenich V; Vidal S; Hofmeister J; Michalopoulos G; Bancila V; Warrot D; Dayer A; Desseilles M; Aubry JM; Kosel M; Schwartz S; Vutskits L
Anesthesiology; 2019 Jun; 130(6):923-935. PubMed ID: 31021848
[TBL] [Abstract][Full Text] [Related]
2. Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression.
Siegel JS; Palanca BJA; Ances BM; Kharasch ED; Schweiger JA; Yingling MD; Snyder AZ; Nicol GE; Lenze EJ; Farber NB
Psychopharmacology (Berl); 2021 Apr; 238(4):1157-1169. PubMed ID: 33483802
[TBL] [Abstract][Full Text] [Related]
3. Effects of ketamine on circadian rhythm and synaptic homeostasis in patients with treatment-resistant depression: A protocol for mechanistic studies of its rapid and sustained antidepressant actions in humans.
Zhuo C; Tian H; Li G; Chen M; Jiang D; Lin X; Xu Y; Wang W
Brain Behav; 2019 Nov; 9(11):e01423. PubMed ID: 31617335
[TBL] [Abstract][Full Text] [Related]
4. Neural correlates of change in major depressive disorder anhedonia following open-label ketamine.
Lally N; Nugent AC; Luckenbaugh DA; Niciu MJ; Roiser JP; Zarate CA
J Psychopharmacol; 2015 May; 29(5):596-607. PubMed ID: 25691504
[TBL] [Abstract][Full Text] [Related]
5. Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression.
Rivas-Grajales AM; Salas R; Robinson ME; Qi K; Murrough JW; Mathew SJ
Int J Neuropsychopharmacol; 2021 May; 24(5):383-391. PubMed ID: 33249434
[TBL] [Abstract][Full Text] [Related]
6. Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study.
Robertson B; Wang L; Diaz MT; Aiello M; Gersing K; Beyer J; Mukundan S; McCarthy G; Doraiswamy PM
J Clin Psychiatry; 2007 Feb; 68(2):261-7. PubMed ID: 17335325
[TBL] [Abstract][Full Text] [Related]
7. Single and repeated ketamine treatment induces perfusion changes in sensory and limbic networks in major depressive disorder.
Sahib AK; Loureiro JRA; Vasavada MM; Kubicki A; Joshi SH; Wang K; Woods RP; Congdon E; Wang DJJ; Boucher ML; Espinoza R; Narr KL
Eur Neuropsychopharmacol; 2020 Apr; 33():89-100. PubMed ID: 32061453
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder.
McMillan R; Sumner R; Forsyth A; Campbell D; Malpas G; Maxwell E; Deng C; Hay J; Ponton R; Sundram F; Muthukumaraswamy S
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109838. PubMed ID: 31843628
[TBL] [Abstract][Full Text] [Related]
9. Mesolimbic interaction of emotional valence and reward improves memory formation.
Wittmann BC; Schiltz K; Boehler CN; Düzel E
Neuropsychologia; 2008 Mar; 46(4):1000-8. PubMed ID: 18191960
[TBL] [Abstract][Full Text] [Related]
10. Modulation of amygdala reactivity following rapidly acting interventions for major depression.
Loureiro JRA; Leaver A; Vasavada M; Sahib AK; Kubicki A; Joshi S; Woods RP; Wade B; Congdon E; Espinoza R; Narr KL
Hum Brain Mapp; 2020 May; 41(7):1699-1710. PubMed ID: 32115848
[TBL] [Abstract][Full Text] [Related]
11. Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression.
Phillips JL; Norris S; Talbot J; Hatchard T; Ortiz A; Birmingham M; Owoeye O; Batten LA; Blier P
Neuropsychopharmacology; 2020 Mar; 45(4):606-612. PubMed ID: 31759333
[TBL] [Abstract][Full Text] [Related]
12. Disentangling the association of depression on the anti-fatigue effects of ketamine.
Saligan LN; Farmer C; Ballard ED; Kadriu B; Zarate CA
J Affect Disord; 2019 Feb; 244():42-45. PubMed ID: 30312839
[TBL] [Abstract][Full Text] [Related]
13. Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study.
Włodarczyk A; Cubała WJ; Gałuszko-Węgielnik M; Szarmach J
Medicine (Baltimore); 2021 Jul; 100(29):e26769. PubMed ID: 34398056
[TBL] [Abstract][Full Text] [Related]
14. The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study.
Li CT; Chen MH; Lin WC; Hong CJ; Yang BH; Liu RS; Tu PC; Su TP
Hum Brain Mapp; 2016 Mar; 37(3):1080-90. PubMed ID: 26821769
[TBL] [Abstract][Full Text] [Related]
15. Neural mechanisms of reinforcement learning in unmedicated patients with major depressive disorder.
Rothkirch M; Tonn J; Köhler S; Sterzer P
Brain; 2017 Apr; 140(4):1147-1157. PubMed ID: 28334960
[TBL] [Abstract][Full Text] [Related]
16. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.
Murrough JW; Burdick KE; Levitch CF; Perez AM; Brallier JW; Chang LC; Foulkes A; Charney DS; Mathew SJ; Iosifescu DV
Neuropsychopharmacology; 2015 Mar; 40(5):1084-90. PubMed ID: 25374095
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological correlates and predictors of the antidepressant response to repeated ketamine infusions in treatment-resistant depression.
de la Salle S; Phillips JL; Blier P; Knott V
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Apr; 115():110507. PubMed ID: 34971723
[TBL] [Abstract][Full Text] [Related]
18. Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.
Ionescu DF; Swee MB; Pavone KJ; Taylor N; Akeju O; Baer L; Nyer M; Cassano P; Mischoulon D; Alpert JE; Brown EN; Nock MK; Fava M; Cusin C
J Clin Psychiatry; 2016 Jun; 77(6):e719-25. PubMed ID: 27232360
[TBL] [Abstract][Full Text] [Related]
19. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Slonena EE; Vande Voort JL; Brutsche NE; Zarate CA
J Clin Psychiatry; 2014 Sep; 75(9):e932-8. PubMed ID: 25295436
[TBL] [Abstract][Full Text] [Related]
20. Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression.
Cornwell BR; Salvadore G; Furey M; Marquardt CA; Brutsche NE; Grillon C; Zarate CA
Biol Psychiatry; 2012 Oct; 72(7):555-61. PubMed ID: 22521148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
